Subscribe free

HPB & Spleen ·

NCI centers improve outcomes in pancreatic cancer surgery

NCI-designated cancer centers lead to better surgical options and survival rates for patients with pancreatic ductal adenocarcinoma (PDAC).

  • Patients at NCI centers had 2.37 times higher odds of surgical resection compared to non-designated centers.
  • One-year mortality was halved (hazard ratio 0.50) for those receiving care at NCI centers.

Access to NCI centers is crucial for delivering coordinated care, particularly in multimodality treatment plans.

  • Multimodality treatment within 180 days post-surgery was significantly higher at NCI centers (56.2%) versus non-NCI (33.4%).

Journal Article by Angez M, Woldesenbet S (…) Pawlik TM et 6 al. in Ann Surg Oncol

© 2026. The Author(s).

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Ann Surg Oncol22 Oct 2026

Pancreatic cancer: occult spread in 1 in 4

In this prospective multicenter cohort, staging laparoscopy found occult metastases in 25% of imaging-M0 patients—including 20.6% with resectable disease—potentially sparing some patients a nonbeneficial resection.

J Gastrointest Surg21 Oct 2026

Primary closure after bile duct exploration: 0.4% leak

In this 743-patient single-center series, laparoscopic bile duct exploration achieved 95.6% stone clearance with a 0.4% bile-leak rate—reassuring results for surgeons considering T-tube-free closure.

All papers in HPB & Spleen →